IDM Pharma, Inc. (IDMI)

[meixatech]

I wonder… Now that the EMEA has approved Mepact, a great deal of uncertainty has been removed and IDMI could be soon announcing their partnership or sale. Just prior to the EMEA announcement, IDMI had reached $2; whereupon that price was knocked down by a relatively large market sale. Could that sale have been a manipulation? That is, it appears that the number of shares it takes to slowly reach $2 is greater than when that number was to knock it down to $1.60. Somebody is slowly accumulating? Since the next apparent step for IDM is the sale, the risk of this strategy is greater than before the EMEA approval and will not likely occur again, if indeed this is what has happened. So, over the time until the announcement occurs, we should not see anymore large percentage drops?